Pharmacologic alternatives for severe atopic dermatitis.
Dicarlo
J B
JB
Emory University School of Medicine, Department of Dermatology, Clinical Pharmacology Unit, Atlanta, Georgia 30322, USA. jdicarl@emory.edu
McCall
C O
CO
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010789:Phototherapy; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D010726:Phosphodiesterase Inhibitors; D007371:Interferon-gamma; D016559:Tacrolimus